ATE80397T1 - Isoxazol- und furanderivate, verfahren zu ihrer herstellung und ihre verwendung als antivirale mittel. - Google Patents

Isoxazol- und furanderivate, verfahren zu ihrer herstellung und ihre verwendung als antivirale mittel.

Info

Publication number
ATE80397T1
ATE80397T1 AT86108745T AT86108745T ATE80397T1 AT E80397 T1 ATE80397 T1 AT E80397T1 AT 86108745 T AT86108745 T AT 86108745T AT 86108745 T AT86108745 T AT 86108745T AT E80397 T1 ATE80397 T1 AT E80397T1
Authority
AT
Austria
Prior art keywords
antivirals
isoxazole
processes
production
furan derivatives
Prior art date
Application number
AT86108745T
Other languages
English (en)
Inventor
Guy Dominic Diana
Philip Michael Carabateas
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Application granted granted Critical
Publication of ATE80397T1 publication Critical patent/ATE80397T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
AT86108745T 1985-07-02 1986-06-26 Isoxazol- und furanderivate, verfahren zu ihrer herstellung und ihre verwendung als antivirale mittel. ATE80397T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75134885A 1985-07-02 1985-07-02
EP86108745A EP0207454B1 (de) 1985-07-02 1986-06-26 Isoxazol- und Furanderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als antivirale Mittel

Publications (1)

Publication Number Publication Date
ATE80397T1 true ATE80397T1 (de) 1992-09-15

Family

ID=25021592

Family Applications (2)

Application Number Title Priority Date Filing Date
AT86108744T ATE107645T1 (de) 1985-07-02 1986-06-26 Durch eine heterocyclische gruppe substituierte phenoxyalkylisoxazole und ihre verwendung als antivirale mittel.
AT86108745T ATE80397T1 (de) 1985-07-02 1986-06-26 Isoxazol- und furanderivate, verfahren zu ihrer herstellung und ihre verwendung als antivirale mittel.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT86108744T ATE107645T1 (de) 1985-07-02 1986-06-26 Durch eine heterocyclische gruppe substituierte phenoxyalkylisoxazole und ihre verwendung als antivirale mittel.

Country Status (21)

Country Link
EP (2) EP0207453B1 (de)
JP (2) JPH0768242B2 (de)
KR (2) KR900001314B1 (de)
AR (4) AR241705A1 (de)
AT (2) ATE107645T1 (de)
AU (2) AU589190B2 (de)
CA (2) CA1280753C (de)
DE (3) DE3689924D1 (de)
DK (2) DK171275B1 (de)
ES (5) ES8802518A1 (de)
FI (2) FI862795A (de)
GR (2) GR861695B (de)
IE (2) IE59755B1 (de)
IL (2) IL79309A (de)
MX (4) MX2954A (de)
MY (1) MY102908A (de)
NO (2) NO164977C (de)
NZ (1) NZ216678A (de)
PH (2) PH23197A (de)
PT (2) PT82891B (de)
ZA (2) ZA864873B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1280753C (en) * 1985-07-02 1991-02-26 Philip Michael Carabateas Process for preparing heterocyclic substituted- phenoxyalkyl isoxazoles and-furans
IE59813B1 (en) * 1986-05-09 1994-04-06 Warner Lambert Co Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them
US5051437A (en) * 1986-06-24 1991-09-24 Sterling Drug Inc. Thiazolylphenoxyalkylisoxazoles, related compounds, and their use as antiviral agents
GB8807275D0 (en) * 1988-03-26 1988-04-27 Synphar Lab Inc Chemical compounds
ES2141076T3 (es) 1988-09-01 2000-03-16 Bayer Ag Proteina del receptor de rinovirus humano que inhibe la infectividad del virus.
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
GB8911158D0 (en) * 1989-05-16 1989-07-05 Janssen Pharmaceutica Nv Antiviral pyridazinamines
US5070090A (en) * 1989-05-15 1991-12-03 Janssen Pharmaceutica N.V. Antipicorpaviral herterocyclic-substituted morpholinyl alkylphenol ethers
US4945164A (en) * 1989-08-18 1990-07-31 Sterling Drug Inc. 1,3,4-Oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents and intermediates thereof
US5110821A (en) * 1989-08-18 1992-05-05 Sterling Drug Inc. 1,3,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
NZ234760A (en) * 1989-08-18 1991-09-25 Sterling Drug Inc Antiviral oxazole compounds and compositions
US4942241A (en) * 1989-08-21 1990-07-17 Sterling Drug Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
US5175178A (en) * 1989-08-21 1992-12-29 Sterling Drug Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
US5686582A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
US5686581A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric form of human rhinovirus receptor protein
EP0468257B1 (de) * 1990-07-20 1999-09-01 Bayer Corporation Multimere Formen des menschlichen Rhinovirus-Rezeptorproteins
IT1247509B (it) * 1991-04-19 1994-12-17 Univ Cagliari Composti di sintesi atti all'impiego nella terapia delle infezioni da rhinovirus
US5175177A (en) * 1991-07-17 1992-12-29 Sterling Drug Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
US5349068A (en) * 1992-04-15 1994-09-20 Sterling Winthrop Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
US5514781A (en) * 1994-04-11 1996-05-07 Bayer Corporation Use of azoles as virucidal agents in solutions of biologically active proteins
US5514679A (en) * 1994-05-13 1996-05-07 Sterling Winthrop Inc. Therapeutic phenoxyalklpyridazines and intermediates therefor
US5453433A (en) * 1994-05-13 1995-09-26 Sterling Winthrop Inc. Thiadiazoles and antipicornaviral compositions
WO2005005423A1 (en) 2003-07-02 2005-01-20 F. Hoffmann-La Roche Ag Indolyl derivatives substituted with a thiazole ring and their use as ppar modulators
EP1866293A1 (de) 2005-03-31 2007-12-19 UCB Pharma, S.A. Eine oxazol- oder thiazolgruppe enthaltende verbindungen, verfahren zu deren herstellung und ihre anwendungen
US8993604B2 (en) 2009-06-30 2015-03-31 Siga Technologies, Inc. Treatment and prevention of dengue virus infections
JP2012532102A (ja) * 2009-06-30 2012-12-13 シガ・テクノロジーズ・インコーポレーテッド デングウイルス感染の治療法および予防法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451476A (en) * 1982-12-13 1984-05-29 Sterling Drug Inc. Isoxazoles as antiviral agents
NZ209209A (en) * 1983-08-29 1988-02-12 Sterling Drug Inc Substituted phenyl-aliphatic isoxazole derivatives and pharmaceutical compositions
CA1280753C (en) * 1985-07-02 1991-02-26 Philip Michael Carabateas Process for preparing heterocyclic substituted- phenoxyalkyl isoxazoles and-furans

Also Published As

Publication number Publication date
JPS6216479A (ja) 1987-01-24
AU5945786A (en) 1987-01-08
DE3686677T2 (de) 1993-03-11
DE3689924T4 (de) 1995-05-11
AR242573A1 (es) 1993-04-30
ATE107645T1 (de) 1994-07-15
ES557778A0 (es) 1988-04-01
FI85021C (fi) 1992-02-25
DE3689924T2 (de) 1995-01-19
IE861724L (en) 1987-01-02
AU589190B2 (en) 1989-10-05
CA1280753C (en) 1991-02-26
IE861723L (en) 1987-01-02
IE59755B1 (en) 1994-03-23
FI85021B (fi) 1991-11-15
EP0207454A2 (de) 1987-01-07
DE3689924D1 (de) 1994-07-28
DK312986D0 (da) 1986-07-01
GR861697B (en) 1986-11-04
EP0207453A3 (en) 1988-11-23
IE66234B1 (en) 1995-12-13
NO165023B (no) 1990-09-03
IL79309A (en) 1990-11-29
FI862795A (fi) 1987-01-03
PT82892A (pt) 1987-01-26
FI862794A (fi) 1987-01-03
EP0207453B1 (de) 1994-06-22
MX2954A (es) 1993-11-01
NO862651L (no) 1987-01-05
IL79308A (en) 1991-01-31
DK173467B1 (da) 2000-12-04
NO862650L (no) 1987-01-05
PT82892B (pt) 1994-09-30
PH23197A (en) 1989-05-29
NO862650D0 (no) 1986-07-01
AU587622B2 (en) 1989-08-24
MX9100029A (es) 1993-01-01
DK171275B1 (da) 1996-08-19
ES8801651A1 (es) 1988-02-16
ZA864873B (en) 1987-02-25
MX9100033A (es) 1993-01-01
JPH0819128B2 (ja) 1996-02-28
NZ216678A (en) 1989-10-27
PT82891A (en) 1986-08-01
DK313086A (da) 1987-01-03
AU5945686A (en) 1987-01-08
DK312986A (da) 1987-01-03
ES557779A0 (es) 1988-02-16
EP0207454B1 (de) 1992-09-09
KR870001202A (ko) 1987-03-12
KR900001314B1 (ko) 1990-03-08
AR242572A1 (es) 1993-04-30
ES557780A0 (es) 1988-02-16
GR861695B (en) 1986-11-04
NO862651D0 (no) 1986-07-01
JPS6216480A (ja) 1987-01-24
DE3686677D1 (de) 1992-10-15
CA1299176C (en) 1992-04-21
NO164977B (no) 1990-08-27
IL79309A0 (en) 1986-10-31
ZA864872B (en) 1987-02-25
ES8802153A1 (es) 1988-04-01
NO165023C (no) 1990-12-12
MX9100032A (es) 1993-01-01
KR870001205A (ko) 1987-03-12
IL79308A0 (en) 1986-10-31
ES556812A0 (es) 1988-07-01
MY102908A (en) 1993-03-31
ES8801649A1 (es) 1988-02-16
NO164977C (no) 1990-12-05
FI862795A0 (fi) 1986-07-01
JPH0768242B2 (ja) 1995-07-26
AR244686A1 (es) 1993-11-30
ES556811A0 (es) 1988-07-01
EP0207454A3 (en) 1988-08-10
FI862794A0 (fi) 1986-07-01
PH22321A (en) 1988-07-29
AR241705A1 (es) 1992-11-30
DK313086D0 (da) 1986-07-01
ES8802517A1 (es) 1988-07-01
PT82891B (pt) 1988-05-27
EP0207453A2 (de) 1987-01-07
KR900001315B1 (ko) 1990-03-08
ES8802518A1 (es) 1988-07-01

Similar Documents

Publication Publication Date Title
ATE80397T1 (de) Isoxazol- und furanderivate, verfahren zu ihrer herstellung und ihre verwendung als antivirale mittel.
ATA312987A (de) Brenzkatechin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneistoffe
DE3784478D1 (de) Benzopyran-verbindungen, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
DE3584463D1 (de) Substituierte naphthyridin-, chinolin- und benzoxazin-carbonsaeuren als bakterizide mittel und verfahren zu ihrer herstellung.
DE3676148D1 (de) Antigerinnungsmittel, verfahren zu seiner herstellung und dieses mittel als wirkender grundstoff enthaltende antikoagulantia.
DE3576500D1 (de) Carbostyrilverbindungen, diese enthaltende zubereitungen und verfahren zu ihrer herstellung.
DE3784401D1 (de) Karbostyril-derivate und ihre salze, verfahren zu ihrer herstellung und diese enthaltende kardiotonische zusammensetzung.
ATE36701T1 (de) Spergualinaehnliche derivate, verfahren zu ihrer herstellung und ihre verwendung als heilmittel.
DE3683210D1 (de) 3-phenylthiomethylstyrolderivate, verfahren zu ihrer herstellung und sie enthaltende antiallergie- und tyrosinekinaseinhibierende mittel.
ATE40826T1 (de) 4'-demethyl-4-epipodophyllotoxinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE60767T1 (de) Aminoacyllabdane, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE32459T1 (de) Substituierte phenylsulfonyloxybenzimidazolcarbaminate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE73758T1 (de) 2,2-difluorcyclopropylethanderivate, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel.
DE3679028D1 (de) Benzylaminderivate, verfahren zu ihrer herstellung und ihre verwendung.
DE58905246D1 (de) Heterocyclische substituierte alkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
ATE38512T1 (de) Phenylen-substituierte, spergualinaehnliche derivate, verfahren zu ihrer herstellung und ihre verwendung als heilmittel.
DE3677812D1 (de) Polyhydroxypolyether, verfahren zu ihrer herstellung und ihre verwendung.
DE3670858D1 (de) Wasserloesliche triphendioxazin-verbindungen, verfahren zu ihrer herstellung und ihre verwendung als farbstoffe.
DE3772897D1 (de) Dialkylmaleinimide, verfahren zu ihrer herstellung und ihre verwendung als herbizide.
DE3687515D1 (de) Oxa-, thia- und diazabicycloalkanderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE56008T1 (de) Benzofuran-2-yl-imidazole mit pharmazeutischer wirkung, ihre salze und relevante verfahren zu ihrer herstellung.
DE3673734D1 (de) Xanthinderivate, verfahren zu ihrer herstellung und ihre verwendung als medikamente.
DE3675812D1 (de) Carbostyrilderivate und ihre salze, verfahren zu ihrer herstellung und diese enthaltende cardiotonische zubereitungen.
DE3770739D1 (de) Morpholin-, piperidin- und tetrahydropyridinderivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
DE68912944D1 (de) Phenylpyrole, verwendbar als arzneimittel, verfahren zu ihrer herstellung und ihre verwendung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee